Inappropriate antibiotics given to 22% of seniors … Use of pain, sleep meds increases frailty risk in the elderly … Triplet study shows that genes aren’t the only factor in Alzheimer’s...
Clinical Briefs for Wednesday, May 27
By
Alicia Lasek
May 26, 2020
White House lowers insulin costs to $35 a month for Medicare enrollees … CMS rule changes aim to increase telehealth access for Medicare Advantage beneficiaries … Sleep disturbances appear to predict...
Clinical briefs for Thursday, Feb. 25
By
Alicia Lasek
Feb 25, 2021
Dementia care report should be ‘catalyst for change,’ committee says … Pain perception may be early disease marker in Alzheimer’s gene carriers … Nursing home first-dose vaccination data released...
Clinical Briefs for Thursday, April 2
By
Alicia Lasek
Apr 01, 2020
FDA orders all Zantac heartburn products off store shelves … Scientists discover gene that increases risk of Alzheimer’s disease … New CDC report adds evidence that underlying conditions raise...
New drug may guard against Alzheimer’s-related memory loss
By
Alicia Lasek
Sep 10, 2019
A new trial drug may help to protect memory – even when a person’s brain has developed signs of Alzheimer’s disease, according to ongoing research.
Alzheimer’s signs may be evident decades before onset: Family history is key
By
Alicia Lasek
Jun 23, 2019
Signs of Alzheimer’s disease may show up four decades before onset, according to a web-based study of 60,000 individuals.
Blood test detects early Alzheimer’s with 94% accuracy
By
Alicia Lasek
Aug 01, 2019
A blood test that helps to detect early Alzheimer’s disease is one step closer to clinical use. Its accuracy and low cost are game changers, researchers say.
Dementia signs, symptoms may be different for Latinos, researchers say
By
Alicia Lasek
May 27, 2021
Cultural practices and disease processes may explain why Latino adults with dementia experience faster functional decline and higher rates of depression and anxiety, investigators say.
Alzheimer’s discoveries show new promise for drug development, expert says
By
Alicia Lasek
Jul 20, 2020
The discovery of new biomarkers — along with a focus on repurposed drugs — are optimistic signs for Alzheimer’s research, according to a five-year analysis.
High amyloid levels linked to early-stage Alzheimer’s
By
Alicia Lasek
Apr 06, 2020
Screening data from an Alzheimer’s drug trial suggests that higher brain amyloid levels exist well before clinical symptoms appear.